Zhou C Y, Xu X J, He J
Department of Obstetrics and Gynecology, Suining Central Hospital of Sichuan Province, Suining 629000, China.
Zhonghua Fu Chan Ke Za Zhi. 2016 Nov 25;51(11):845-849. doi: 10.3760/cma.j.issn.0529-567X.2016.11.009.
To investigate the symptom improvement and pregnancy outcomes of patients with adenomyosis after treatment with high intensity focused ultrasound (HIFU) ablation. From October 2010 to October 2015, 68 patients with adenomyosis who wish to get pregnancies were treated with HIFU ablation in Suining Central Hospital. Among these patients, 56 presented with dysmenorrhea, 11 presented with menorrhagia, and 1 patient complained both; 41 of them had histories of abnormal pregnancy. The clinical data were analyzed retrospectively. Fifty-four patients got pregnancy at the median of 10 months(range:1 to 31 months) after HIFU ablation, and 21 of them had delivered healthy babies. No uterine rupture occurred during gestation or delivery, and the newborn babies were healthy. Dysmenorrhea and menorrhagia in the patients who had pregnancies after HIFU ablation treatment were significantly relieved. The average menstruation volume score before and 1, 3, 6-month post-HIFU were 2.6±1.7, 1.7±0.8, 1.4±0.6, 1.3±0.6, respectively (0.05). The menstruation pain score before and 1, 3, 6-month after HIFU were 1.4±0.9, 0.9±0.7, 0.6±0.5, and 0.9±0.7, respectively (0.05). The volume of the adenomyotic lesions before and after HIFU at 1, 3, 6 month were (34±23), (23±15), (20±17), (20±12) cm (0.05). Although the spontaneous abortion rate was decreased after HIFU ablation treatment, there was no significant difference between the preoperative and postoperative [43% (23/54) versus 37% (20/54), 0.05]. However, 20 of the 54 patients had spontaneous abortion, compared with 21 patients who had delivered babies, there were no significant statistical difference in terms of age, duration of disease, lesion size, non-perfused volume ratio, as well as the symptom scores before and after HIFU ablation treatment. HIFU ablation treatment is effective in improving symptoms of patients with adenomyosis. Based on our results, HIFU ablation treatment maybe also help to improve the pregnancy outcomes of patients with adenomyosis, but further studies are needed.
探讨高强度聚焦超声(HIFU)消融治疗子宫腺肌病患者的症状改善情况及妊娠结局。2010年10月至2015年10月,遂宁市中心医院对68例有妊娠意愿的子宫腺肌病患者进行了HIFU消融治疗。其中,56例有痛经,11例有月经过多,1例两者均有;41例有异常妊娠史。对临床资料进行回顾性分析。54例患者在HIFU消融术后中位数10个月(范围:1至31个月)妊娠,其中21例分娩健康婴儿。妊娠期或分娩期未发生子宫破裂,新生儿健康。HIFU消融治疗后妊娠患者的痛经和月经过多症状明显缓解。HIFU术前及术后1、3、6个月的平均月经量评分分别为2.6±1.7、1.7±0.8、1.4±0.6、1.3±0.6(P<0.05)。HIFU术前及术后1、3、6个月的痛经评分分别为1.4±0.9、0.9±0.7、0.6±0.5、0.9±0.7(P<0.05)。HIFU术前及术后1、3、6个月的子宫腺肌病病灶体积分别为(34±23)、(23±15)、(20±17)、(20±12)cm³(P<0.05)。虽然HIFU消融治疗后自然流产率有所下降,但术前与术后比较差异无统计学意义[43%(23/54)对37%(20/54),P>0.05]。然而,54例患者中有20例自然流产,与21例分娩婴儿的患者相比,在年龄、病程、病灶大小、非灌注体积比以及HIFU消融治疗前后的症状评分方面,差异均无统计学意义。HIFU消融治疗可有效改善子宫腺肌病患者的症状。根据我们的结果,HIFU消融治疗可能也有助于改善子宫腺肌病患者的妊娠结局,但仍需进一步研究。